Fredun Pharmaceuticals Ltd (539730) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 539730 | NSE: | Pharmaceuticals & Drugs | Small Cap

Fredun Pharma Share Price

1,880 -27.05 -1.42%
as on 05-Dec'25 12:17

Fredun Pharmaceuticals Ltd (539730) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 539730 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Fredun Pharma

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Fredun Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
31.16
Market Cap:
900.4 Cr.
52-wk low:
635
52-wk high:
1,999

Is Fredun Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Fredun Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Fredun Pharmaceuticals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 24.7%18.2%15.9%20.6%10.4%9.5%13.2%17.6%17.1%18.9%-
Value Creation
Index
0.80.30.10.5-0.3-0.3-0.10.30.20.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 42.356.759.697113134224275348454530
Sales YoY Gr.-34%5%62.9%16.2%18.7%67.7%22.4%26.8%30.4%-
Adj EPS 4.43.54.911.54.44.912.421.632.24461.2
YoY Gr.--20.7%38.4%136.6%-62.2%13.3%151.6%73.5%49.3%36.7%-
BVPS (₹) 15.720.164.797.7103.6108153.1194.3255.2299.5333.7
Adj Net
Profit
1.10.81.74.61.725.59.815.120.829
Cash Flow from Ops. 3.3417.30.8-10.60.2-2.4-14.4-0.4-28.9-
Debt/CF from Ops. 4.74.60.623.1-3.3233.3-22.2-6-240.5-5.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 30.2%32.1%26.5%30.4%
Adj EPS 29%58.8%52.4%36.7%
BVPS38.8%23.7%25.1%17.4%
Share Price - 46.3% 11.6% 141%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
29.714.811.3154.34.79.911.913.915.819.3
Op. Profit
Mgn %
9.869.610.57.476.210.110.911.813.2
Net Profit
Mgn %
2.51.52.84.71.51.52.53.64.34.65.5
Debt to
Equity
3.92.50.50.50.80.90.810.91.20.2
Working Cap
Days
174200261230290324230244248276119
Cash Conv.
Cycle
2812-31159811110013514916632

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Fredun Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 61.2 41.8
TTM Sales (₹ Cr.) 530 454
BVPS (₹.) 333.7 333
Reserves (₹ Cr.) 153 153
P/BV 5.71 5.73
PE 31.16 45.62
From the Market
52 Week Low / High (₹) 635.00 / 1999.00
All Time Low / High (₹) 12.50 / 1999.00
Market Cap (₹ Cr.) 900
Equity (₹ Cr.) 4.7
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Fredun Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Fredun Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Fredun Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales42576097113134224275348454
Operating Expenses 38535487104125211247310401
Manufacturing Costs111737768111521
Material Costs1925406082102177209261330
Employee Cost 45589911121222
Other Costs 576127815162228
Operating Profit 436108914283853
Operating Profit Margin (%) 9.2%5.9%9.6%10.3%7.4%7.0%6.2%10.1%10.9%11.6%
Other Income 1201112212
Interest 222344591422
Depreciation 1111222344
Exceptional Items -00000-10000
Profit Before Tax 2236239182128
Tax 1112112767
Profit After Tax 1124226111621
PAT Margin (%) 2.5%2.5%2.9%4.6%1.7%1.5%2.8%3.9%4.5%4.6%
Adjusted EPS (₹)4.55.44.211.24.85.114.323.833.344.1
Dividend Payout Ratio (%)13%11%14%6%14%14%5%3%2%2%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 47223941436888120141
Share Capital 3534444555
Reserves 12193537396384115137
Minority Interest0000000000
Debt1315101935405383100159
Long Term Debt67011112942151310
Short Term Debt781092311116887150
Trade Payables162339344660495963145
Others Liabilities 1011813191918272541
Total Liabilities 435679105141162187257308487

Fixed Assets

Gross Block21282535373842526980
Accumulated Depreciation67946810132327
Net Fixed Assets 15211631313032394753
CWIP 00110000000
Investments 0000000012
Inventories1071841506846150175240
Trade Receivables112015183941903565177
Cash Equivalents 1111312315
Others Assets 681714182116301911
Total Assets 435679105141162187257308487

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 34171-110-2-14-0-29
PBT 2226229172128
Adjustment 2232698121727
Changes in Working Capital -0-013-7-19-10-19-44-39-84
Tax Paid 0000000000
Cash Flow From Investing Activity -6-7-8-5-1-1-4-9-8-6
Capex -7-3-1-16-1-1-4-9-8-6
Net Investments 0000000000
Others 1-4-711000000
Cash Flow From Financing Activity 33-8414-1725638
Net Proceeds from Shares 52-11000000
Net Proceeds from Borrowing 00-47118137-3-3
Interest Paid -2-2-2-3-4-4-5-9-14-22
Dividend Paid 0000000000
Others 02-1-017-14-1282264
Net Cash Flow 1-1102-211-23

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)33.4633.8813.0214.594.744.7711.4213.8615.0315.93
ROCE (%)24.6718.1615.920.5610.369.5313.1517.6417.1318.94
Asset Turnover Ratio1.281.140.881.050.920.881.291.241.231.14
PAT to CFO Conversion(x)348.50.25-5.50-0.33-1.27-0-1.38
Working Capital Days
Receivable Days721021096292109107835297
Inventory Days63557811114816193131170167
Payable Days2232902852211781901129485115

Fredun Pharmaceuticals Ltd Stock News

Fredun Pharmaceuticals Ltd FAQs

The current trading price of Fredun Pharma on 05-Dec-2025 12:17 is ₹1,880.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Fredun Pharma stood at ₹900.4.
The latest P/E ratio of Fredun Pharma as of 04-Dec-2025 is 31.16.
The latest P/B ratio of Fredun Pharma as of 04-Dec-2025 is 5.71.
The 52-week high of Fredun Pharma is ₹1,999 and the 52-week low is ₹635.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fredun Pharma is ₹530.3 ( Cr.) .

About Fredun Pharmaceuticals Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×